1	7 if felbamate be use as a concomitant aed subject must be on felbamate for at least 2 year with a stable dose for 60 day prior to baseline they must not have a history of white blood cell wbc count below less than or euqal to 2500/microl 2.50 1e+09/l platelet less than 100,000/microl liver|felbamate[5,14]|||||||60 day[115,121]||C0060135|24812|24812|felbamate
1	7 if felbamate be use as a concomitant aed subject must be on felbamate for at least 2 year with a stable dose for 60 day prior to baseline they must not have a history of white blood cell wbc count below less than or euqal to 2500/microl 2.50 1e+09/l platelet less than 100,000/microl liver|felbamate[62,71]|||||||||C0060135|24812|24812|felbamate
2	function test lfts great than 3 time the upper limit of normal uln or other indication of hepatic or bone marrow dysfunction while receive felbamate|felbamate[431,440]|||||||||C0060135|24812|24812|felbamate
